經鼻高流量氧療在慢性阻塞性肺疾病急性加重期的研究進展_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

 馬德勝 ¹ , 甄玲玲 ² ,  馬莉 ¹ , 蒙雁飛 ¹

1. ;
2. ;

Corresponding?author：

馬莉, Email: ery_mali@lzu.edu.cn

Keywords：

DOI：

10.7507/1671-6205.202003085

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 馬德勝, 甄玲玲, 馬莉, 蒙雁飛. 經鼻高流量氧療在慢性阻塞性肺疾病急性加重期的研究進展. Chinese Journal of Respiratory and Critical Care Medicine, 2022, 21(9): 670-673. doi: 10.7507/1671-6205.202003085 Copy

1.	Wang C, Xu JY, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health study): a national cross-sectional study. Lancet, 2018, 391(10131): 1706-1717.
2.	Pisani L, Vega ML. Use of nasal high flow in stable COPD: rationale and physiology. COPD, 2017, 14(3): 346-350.
3.	European Respiratory Society. European Respiratory Society’s white book. Sheffield: European Respiratory Society, 2016.
4.	Singh D. Pharmacological treatment for COPD; GOLD 2017 changes direction. Br J Clin Pharmacol, 2017, 83(5): 935-937.
5.	Kim DK, Lee J, Park JH, et al. What can we apply to manage acute exacerbation of chronic obstructive pulmonary disease with acute respiratory failure?. Tuberc Respir Dis, 2018, 81(2): 99-105.
6.	Hernández G, Roca O, Colinas L. High-flow nasal cannula support therapy: new insights and improving performance. Crit Care, 2017, 21: 62.
7.	Schreiber A, DI Marco F, Braido F, et al. High flow nasal cannula oxygen therapy, work in progress in respiratory critical care. Minerva Med, 2016, 107(6 Suppl 1): 14-20.
8.	Nishimura M. High-flow nasal cannula oxygen therapy in adults: physiological benefits, indication, clinical benefits, and adverse effects. Respir Care, 2016, 61(4): 529-541.
9.	Mauri T, Turrini C, Eronia N, et al. Physiologic effects of high-flow nasal cannula in acute hypoxemic respiratory failure. Am J Respir Crit Care Med, 2017, 195(9): 1207-1215.
10.	Roca O, Riera J, Torres F, et al. High-flow oxygen therapy in acute respiratory failure. Respir Care, 2010, 55(4): 408-413.
11.	Parke RL, Bloch A, McGuinness SP. Effect of very-high-flow nasal therapy on airway pressure and end-expiratory lung impedance in healthy volunteers. Respir Care, 2015, 60(10): 1397-1403.
12.	Frat JP, Thille AW, Mercat A, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med, 2015, 372(23): 2185-2196.
13.	Papazian L, Corley A, Hess D, et al. Use of high flow nasal cannula oxygenation in ICU adults: a narrative review. Intensive Care Med, 2016, 42(9): 1336-1349.
14.	Silva Santos P, Esquinas AM. The use of high-flow nasal oxygen in COPD patients. Int J Chron Obstruct Pulmon Dis, 2016, 11: 2259-2260.
15.	García-Rivero JL, Esquinas C, Barrecheguren M, et al. Risk factors of poor outcomes after admission for a COPD exacerbation: multivariate logistic predictive models. COPD, 2017, 14(2): 164-169.
16.	Mauri T, Alban L, Turrini C, et al. Optimum support by high-flow nasal cannula in acute hypoxemic respiratory failure: effects of increasing flow rates. Intensive Care Med, 2017, 43(10): 1453-1463.
17.	M?ller W, Celik G, Feng S, et al. Nasal high flow clears anatomical dead space in upper airway models. J Appl Physiol, 2015, 118(12): 1525-1532.
18.	Biselli PJC, Kirkness JP, Grote L, et al. Nasal high-flow therapy reduces work of breathing compared with oxygen during sleep in COPD and smoking controls: a prospective observational study. J Appl Physiol, 2017, 122(1): 82-88.
19.	王翠, 施敏驊. 經鼻高流量氧療治療慢性阻塞性肺疾病急性加重合并Ⅱ型呼吸衰竭的臨床療效觀察. 中國呼吸與危重監護雜志, 2021, 20(11): 807-812.
20.	Stéphan F, Barrucand B, Petit P, et al. High-flow nasal oxygen vs noninvasive positive airway iressure in hypoxemic patients after cardiothoracic surgery: a randomized clinical trial. JAMA, 2015, 313(23): 2331-2339.
21.	Dysart K, Miller TL, Wolfson MR, et al. Research in high flow therapy: mechanisms of action. Respir Med, 2009, 103(10): 1400-1405.
22.	Mittal A, Varshney M, Rathi V, et al. High flow nasal cannula in acute hypercapnic exacerbation of chronic obstructive pulmonary disease: an emerging utility. Monaldi Arch Chest Dis, 2020, 90(1).
23.	Plotnikow G, Thille AW, Vasquez D, et al. High-flow nasal cannula oxygen for reverting severe acute exacerbation of chronic obstructive pulmonary disease: a case report. Med Intensiva, 2017, 41(9): 571-572.
24.	Pilcher J, Eastlake L, Richards M, et al. Physiological effects of titrated oxygen via nasal high-flow cannulae in COPD exacerbations: a randomized controlled cross-over trial. Respirology, 2017, 22(6): 1149-1155.
25.	Br?unlich J, Wirtz H. Nasal high-flow in acute hypercapnic exacerbation of COPD. Int J Chron Obstruct Pulmon Dis, 2018, 13: 3895-3897.
26.	王建軍, 姜宏英, 李勍, 等. 經鼻高流量濕化氧療與無創正壓通氣治療慢性阻塞性肺疾病急性加重伴Ⅱ型呼吸衰竭的隨機對照研究. 中國急救醫學, 2019, 39(10): 945-948.
27.	陳棟玉, 何磊, 周亮亮, 等. 有創機械通氣–高流量氧療序貫治療慢性阻塞性肺疾病所致急性呼吸衰竭的臨床研究. 中華重癥醫學電子雜志(網絡), 2019, 5(3): 219-224.
28.	Weingart SD, Levitan RM. Preoxygenation and prevention of desaturation during emergency airway management. Ann Emerg Med, 2012, 59(3): 165-175.
29.	Miguel-Montanes R, Hajage D, Messika J, et al. Use of high-flow nasal cannula oxygen therapy to prevent desaturation during tracheal intubation of intensive care patients with mild-to-moderate hypoxemia. Crit Care Med, 2015, 43(3): 574-583.
30.	Guitton C, Ehrmann S, Volteau C, et al. Nasal high-flow preoxygenation for endotracheal intubation in the critically ill patient: a randomized clinical trial. Intensive Care Med, 2019, 45(4): 447-458.
31.	Frat JP, Ricard JD, Quenot JP, et al. Non-invasive ventilation versus high-flow nasal cannula oxygen therapy with apnoeic oxygenation for preoxygenation before intubation of patients with acute hypoxaemic respiratory failure: a randomised, multicentre, open-label trial. Lancet Respir Med, 2019, 7(4): 303-312.
32.	Xu ZH, Li YM, Zhou JM, et al. High-flow nasal cannula in adults with acute respiratory failure and after extubation: a systematic review and meta-analysis. Respir Res, 2018, 19(1): 202.
33.	Jing GQ, Li J, Hao D, et al. Comparison of high flow nasal cannula with noninvasive ventilation in chronic obstructive pulmonary disease patients with hypercapnia in preventing postextubation respiratory failure: a pilot randomized controlled trial. Res Nurs Health, 2019, 42(3): 217-225.
34.	陳俊, 石建國, 陳想貴, 等. 經鼻高流量氧療在慢性阻塞性肺疾病急性加重患者有創呼吸機序貫治療中的臨床效果. 內科急危重癥雜志, 2019, 25(5): 394-396, 406.
35.	Di Mussi R, Spadaro S, Stripoli T, et al. High-flow nasal cannula oxygen therapy decreases postextubation neuroventilatory drive and work of breathing in patients with chronic obstructive pulmonary disease. Crit Care, 2018, 22(1): 180.

1. Wang C, Xu JY, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health study): a national cross-sectional study. Lancet, 2018, 391(10131): 1706-1717.
2. Pisani L, Vega ML. Use of nasal high flow in stable COPD: rationale and physiology. COPD, 2017, 14(3): 346-350.
3. European Respiratory Society. European Respiratory Society’s white book. Sheffield: European Respiratory Society, 2016.
4. Singh D. Pharmacological treatment for COPD; GOLD 2017 changes direction. Br J Clin Pharmacol, 2017, 83(5): 935-937.
5. Kim DK, Lee J, Park JH, et al. What can we apply to manage acute exacerbation of chronic obstructive pulmonary disease with acute respiratory failure?. Tuberc Respir Dis, 2018, 81(2): 99-105.
6. Hernández G, Roca O, Colinas L. High-flow nasal cannula support therapy: new insights and improving performance. Crit Care, 2017, 21: 62.
7. Schreiber A, DI Marco F, Braido F, et al. High flow nasal cannula oxygen therapy, work in progress in respiratory critical care. Minerva Med, 2016, 107(6 Suppl 1): 14-20.
8. Nishimura M. High-flow nasal cannula oxygen therapy in adults: physiological benefits, indication, clinical benefits, and adverse effects. Respir Care, 2016, 61(4): 529-541.
9. Mauri T, Turrini C, Eronia N, et al. Physiologic effects of high-flow nasal cannula in acute hypoxemic respiratory failure. Am J Respir Crit Care Med, 2017, 195(9): 1207-1215.
10. Roca O, Riera J, Torres F, et al. High-flow oxygen therapy in acute respiratory failure. Respir Care, 2010, 55(4): 408-413.
11. Parke RL, Bloch A, McGuinness SP. Effect of very-high-flow nasal therapy on airway pressure and end-expiratory lung impedance in healthy volunteers. Respir Care, 2015, 60(10): 1397-1403.
12. Frat JP, Thille AW, Mercat A, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med, 2015, 372(23): 2185-2196.
13. Papazian L, Corley A, Hess D, et al. Use of high flow nasal cannula oxygenation in ICU adults: a narrative review. Intensive Care Med, 2016, 42(9): 1336-1349.
14. Silva Santos P, Esquinas AM. The use of high-flow nasal oxygen in COPD patients. Int J Chron Obstruct Pulmon Dis, 2016, 11: 2259-2260.
15. García-Rivero JL, Esquinas C, Barrecheguren M, et al. Risk factors of poor outcomes after admission for a COPD exacerbation: multivariate logistic predictive models. COPD, 2017, 14(2): 164-169.
16. Mauri T, Alban L, Turrini C, et al. Optimum support by high-flow nasal cannula in acute hypoxemic respiratory failure: effects of increasing flow rates. Intensive Care Med, 2017, 43(10): 1453-1463.
17. M?ller W, Celik G, Feng S, et al. Nasal high flow clears anatomical dead space in upper airway models. J Appl Physiol, 2015, 118(12): 1525-1532.
18. Biselli PJC, Kirkness JP, Grote L, et al. Nasal high-flow therapy reduces work of breathing compared with oxygen during sleep in COPD and smoking controls: a prospective observational study. J Appl Physiol, 2017, 122(1): 82-88.
19. 王翠, 施敏驊. 經鼻高流量氧療治療慢性阻塞性肺疾病急性加重合并Ⅱ型呼吸衰竭的臨床療效觀察. 中國呼吸與危重監護雜志, 2021, 20(11): 807-812.
20. Stéphan F, Barrucand B, Petit P, et al. High-flow nasal oxygen vs noninvasive positive airway iressure in hypoxemic patients after cardiothoracic surgery: a randomized clinical trial. JAMA, 2015, 313(23): 2331-2339.
21. Dysart K, Miller TL, Wolfson MR, et al. Research in high flow therapy: mechanisms of action. Respir Med, 2009, 103(10): 1400-1405.
22. Mittal A, Varshney M, Rathi V, et al. High flow nasal cannula in acute hypercapnic exacerbation of chronic obstructive pulmonary disease: an emerging utility. Monaldi Arch Chest Dis, 2020, 90(1).
23. Plotnikow G, Thille AW, Vasquez D, et al. High-flow nasal cannula oxygen for reverting severe acute exacerbation of chronic obstructive pulmonary disease: a case report. Med Intensiva, 2017, 41(9): 571-572.
24. Pilcher J, Eastlake L, Richards M, et al. Physiological effects of titrated oxygen via nasal high-flow cannulae in COPD exacerbations: a randomized controlled cross-over trial. Respirology, 2017, 22(6): 1149-1155.
25. Br?unlich J, Wirtz H. Nasal high-flow in acute hypercapnic exacerbation of COPD. Int J Chron Obstruct Pulmon Dis, 2018, 13: 3895-3897.
26. 王建軍, 姜宏英, 李勍, 等. 經鼻高流量濕化氧療與無創正壓通氣治療慢性阻塞性肺疾病急性加重伴Ⅱ型呼吸衰竭的隨機對照研究. 中國急救醫學, 2019, 39(10): 945-948.
27. 陳棟玉, 何磊, 周亮亮, 等. 有創機械通氣–高流量氧療序貫治療慢性阻塞性肺疾病所致急性呼吸衰竭的臨床研究. 中華重癥醫學電子雜志(網絡), 2019, 5(3): 219-224.
28. Weingart SD, Levitan RM. Preoxygenation and prevention of desaturation during emergency airway management. Ann Emerg Med, 2012, 59(3): 165-175.
29. Miguel-Montanes R, Hajage D, Messika J, et al. Use of high-flow nasal cannula oxygen therapy to prevent desaturation during tracheal intubation of intensive care patients with mild-to-moderate hypoxemia. Crit Care Med, 2015, 43(3): 574-583.
30. Guitton C, Ehrmann S, Volteau C, et al. Nasal high-flow preoxygenation for endotracheal intubation in the critically ill patient: a randomized clinical trial. Intensive Care Med, 2019, 45(4): 447-458.
31. Frat JP, Ricard JD, Quenot JP, et al. Non-invasive ventilation versus high-flow nasal cannula oxygen therapy with apnoeic oxygenation for preoxygenation before intubation of patients with acute hypoxaemic respiratory failure: a randomised, multicentre, open-label trial. Lancet Respir Med, 2019, 7(4): 303-312.
32. Xu ZH, Li YM, Zhou JM, et al. High-flow nasal cannula in adults with acute respiratory failure and after extubation: a systematic review and meta-analysis. Respir Res, 2018, 19(1): 202.
33. Jing GQ, Li J, Hao D, et al. Comparison of high flow nasal cannula with noninvasive ventilation in chronic obstructive pulmonary disease patients with hypercapnia in preventing postextubation respiratory failure: a pilot randomized controlled trial. Res Nurs Health, 2019, 42(3): 217-225.
34. 陳俊, 石建國, 陳想貴, 等. 經鼻高流量氧療在慢性阻塞性肺疾病急性加重患者有創呼吸機序貫治療中的臨床效果. 內科急危重癥雜志, 2019, 25(5): 394-396, 406.
35. Di Mussi R, Spadaro S, Stripoli T, et al. High-flow nasal cannula oxygen therapy decreases postextubation neuroventilatory drive and work of breathing in patients with chronic obstructive pulmonary disease. Crit Care, 2018, 22(1): 180.

Previous Article
1型神經纖維瘤病患者胸脊膜膨出誤診為包裹性胸腔積液一例
Next Article
宏基因組學二代測序在結核病診斷中的應用現狀及發展前景

Chinese Journal of Respiratory and Critical Care Medicine

經鼻高流量氧療在慢性阻塞性肺疾病急性加重期的研究進展

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content